When a Texas widow recounted the tragic death of her husband, she highlighted how a prior‑authorization requirement for a nebulizer medication may have contributed to his suicide, raising concerns about insurance delays for life‑saving treatments.
Family’s Account of a Fatal Delay
Cindy Clements Blewett, a resident of Kyle, Texas, wrote that her husband, Kenney Blewett, was 78 when he died on June 7 after a severe COPD exacerbation. The pulmonologist had prescribed two nebulizer therapies on June 2. One medication, a specialty drug, was shipped directly from the manufacturer, but the second needed prior authorization from the insurer.
She said the pharmacy called her to explain the hold and promised to forward the request to the doctor. “Why the doctor who prescribed it needed to tell his health insurer that he really did think his patient needed it, I will never understand,” she wrote, adding that the pharmacist had not initiated the request earlier.
Related: Trump Nominee for CDC Commends Vaccines, Won’t Promise Independence
By the time the authorization was finally processed, the medication still had not been dispensed. The family received a “welcome” packet for the second nebulizer 25 days after the prescription was written, well after the fatal event.
Impact of the Authorization Process
Blewett described the day of the flare‑up: she was mowing the yard while her husband struggled to breathe at home. “How terrifying it must have been for him to be unable to breathe and me not being there at least to hold his hand,” she wrote, noting that the isolation intensified his distress.
Kenney left a note expressing that he could not endure the constant anxiety of not knowing when he would be able to draw a breath. He had previously attempted suicide six years earlier after the loss of their daughter and granddaughter, but had vowed never to try again. The recent increase in COPD flare‑ups, according to his wife, pushed him over the edge.
Related: Missouri Considers Tax on Medical Care
She suggested that timely access to both prescribed medications might have prevented the tragedy, stating, “Perhaps, just perhaps, if he had received both medications in a timely manner, he would be here today.” The couple had been together since they were 16, a partnership spanning over six decades.
While the family’s grief is personal, the situation reflects systemic challenges in the U.S. health‑care system, where administrative hurdles sometimes intersect with critical medical needs.
The family’s letter calls for a review of how prior‑authorization policies are applied, especially for drugs that are essential to prevent life‑threatening episodes. It also raises the question of whether health‑care providers and insurers can improve communication to avoid such fatal delays.
